PurposeMed

PurposeMed

Private
CalgaryHealthcare & Life Scienceshttps://purposemed.com

Last Round

Growth Equity

Mar 4, 2025

Total Funding Raised

$2.59M

Company Overview

PurposeMed is a healthtech company that provides a telehealth platform for specialized healthcare services to underserved communities in Canada and the United States.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Mental Health, Patient Engagement, Pharma Supply Chain

Business Model

B2C

Customer Profile

Services & Consulting, Government Contracts, Usage-Based SaaS

AI Layer

Non-AI

Keywords

gender-affirming careadult ADHD diagnosisPrEPtelehealth platformvirtual healthcaretelemedicineHRTtrans healthcareLGBTQ+ healthcareADHD treatmentHIV preventionprescription deliveryvirtual cliniconline pharmacydirect-to-consumer healthcareDTC healthfee-for-service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PurposeMed Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PurposeMed Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Growth EquityMar 4, 2025
DebtMar 15, 2024
GrantJan 18, 2023
SeedJun 30, 2021

Key People

Founding team and executive leadership

Amaan Banwait

Co-Founder And Chief Commercial Officer

Founding Team

Pete MacLeod

Co-Founder COO

Founding Team

Husein Moloo

CEO Co-Founder

Founding Team

Craig Dunk

CTO

Executive Team

PurposeMed Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Partnering with the University of Calgary, HIV CTN, and Alberta Innovates.

  • Apr 22, 2026

    Serves thousands of patients monthly through specialized care.

PurposeMed Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PurposeMed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PurposeMed's valuation, stock price, and market status.

Firmographic Details

HeadquartersCalgary
Employee Range146
Year Founded2019
Last FundingMar 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.